Expands the existing law regarding collaborative practice agreements between pharmacists and physicians to allow other healthcare providers to enter into such agreements and removes the definition of “collaborative practice committee.”

Rhode Island Bill Summary: Expanding Pharmacist Collaborative Practice Agreements

This bill expands an existing Rhode Island law that allows pharmacists and physicians to work together under formal "collaborative practice agreements." Currently, these agreements let a pharmacist take on certain clinical tasks — like adjusting medication doses or managing a patient's drug therapy — but only when partnered with a medical doctor. This bill would open that arrangement up to a broader range of healthcare providers, meaning pharmacists could enter into these collaborative agreements with providers such as nurse practitioners or physician assistants, not just physicians.

The bill also removes the legal definition of a "collaborative practice committee" from state law, streamlining the existing framework. This is essentially a housekeeping change that simplifies the rules governing how these partnerships are structured and documented.

The people most directly affected are pharmacists, physicians, and other licensed healthcare providers in Rhode Island, as well as patients who receive care from them. For patients — particularly those managing chronic conditions like diabetes or high blood pressure — this could mean more flexible access to pharmacy-based care, since pharmacists would be able to collaborate with a wider variety of their healthcare team members. For healthcare providers, it creates more options for building team-based care arrangements.

As of now, the bill has been referred to the Senate Health and Human Services Committee and has been held for further study, meaning it has not yet moved forward in the legislative process.